Colao A, Di Sarno A, Sarnacchiaro F, et al. Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment. J Clin Endocrinol Metab. 1997;82:876-83.

Molitch ME. Pregnancy and the hyperprolactinemic woman. N Engl J Med. 1985;312:1364-70.

Molitch ME, Elton RL, Blackwell RE, et al. Bromocriptine Study Group: bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. J Clin Endocrinol Metab. 1985;60:698-705.

Molitch ME, Thorner MO, Wilson C. Therapeutic controversy: management of prolactinomas. J Clin Endocrinol Metab. 1996;82: 996-1000.

Thorner MO, McNeilly AS, Hagan C, Besser GM. Long-term treatment of galactorrhoea and hypogonadism with bromocriptine. Br Med J. 1974;2:419-22.

Thorner MO, Perryman RL, Rogol AD, et al. Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine. J Clin Endocrinol Metab. 1981;53:480-3.

Thorner MO, Martin WH, Rogol AD, et al. Rapid regression of pituitary prolactinomas during bromocriptine treatment. J Clin Endocrinol Metab. 1980;51:438-45.

Turkalj I, Braun P, Krupp P. Surveillance of bromocriptine in pregnancy. JAMA. 1982;247:1589-91.

Vance ML, Evans WS, Thorner MO. Drugs five years later: bromocriptine. Ann Intern Med. 1984;100:78-91.

Webster J, Piscitelli G, Polli A, Ferrari CI, Ismail I, Scanlon MF. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group. N Engl J Med. 1994;331:904-9.

Glezer A, Soares CR, Vieira JG, Giannella-Neto D, Ribela MT, Goffin V, Bronstein MD. Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay. J Clin Endocrinol Metab. 2006;91:1048-55

Bronstein MD. Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy. Nat Clin Pract Endocrinol Metab. 2006;2:130-1

Bronstein MD. Prolactinomas and pregnancy.Bronstein MD. Pituitary. 2005;8:31-8

Casanueva FF, Molitch ME, Schlechte JA, et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf). 2006;65:265-73.